3 of the very best ASX shares to buy now

These shares are highly rated by the team at Bell Potter for a reason.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX.

Analysts at Bell Potter have recently named a select group of ASX shares they believe represent the very best opportunities on the market right now.

Here are three of Bell Potter's top-rated shares to buy now — and why they're backed to outperform.

Happy shareholders clap and smile as they listen to a company earnings report.

Image source: Getty Images

James Hardie Industries plc (ASX: JHX)

The first ASX share that could be a best buy according to Bell Potter is James Hardie. It is the dominant player in fibre cement and internal lining solutions — and it is particularly well positioned in the U.S. residential market, where a structural shift is taking place away from timber and vinyl towards more durable and lower-maintenance options like fibre cement.

Bell Potter believes this macro trend is set to continue, giving James Hardie a powerful multi-year tailwind. Following a recent pullback in the share price, the broker sees a compelling buying opportunity. It commented:

In our view, JHX is poised for continued earnings expansion, driven by the structural shift towards fibre cement in the US. Households in the US continue to shift to fibre cement cladding from vinyl/timber, providing a multi-year runway for JHX's revenue and profit growth.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix is quickly establishing itself as one of the most promising ASX healthcare shares. The company has successfully commercialised Illuccix, a prostate cancer imaging agent, and has multiple product launches and clinical trial readouts expected over the next two years.

The broker sees Telix as uniquely positioned in the growing field of radiopharmaceuticals, where demand for precision diagnostics and targeted therapies is accelerating. It also points to Telix's strong earnings growth outlook and attractive valuation. It said:

Valuations are attractive, with 12MF P/E now at 41x, supported by a 2yr EPS CAGR of 44%.

WiseTech Global Ltd (ASX: WTC)

A third ASX share that could be a best buy is WiseTech Global. It is the dominant force in global freight forwarding software. Its flagship CargoWise platform is mission-critical for some of the world's biggest logistics players, offering integration, automation, and efficiency at scale.

Bell Potter sees ongoing growth through both organic expansion and strategic acquisitions, with the company set to benefit from global supply chain digitisation and further product rollouts. The broker said:

WTC is a growth story with strategic acquisitions representing upside potential enabling WTC to benefit from large-scale global rollouts and consolidation within the logistics sector.

Motley Fool contributor James Mickleboro has positions in WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »

Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
Broker Notes

Buy, hold, sell: Nick Scali, Nyrada, Wesfarmers shares

Experts reveal their ratings on three ASX shares in the retail and biotech segments. 

Read more »

A young woman smiling and looking happy, indicating a positive share price movement on the ASX market.
Broker Notes

8 ASX 200 shares with renewed buy ratings this week

Brokers retained a positive view on CSL, GQG Partners, ANZ, and other shares this week. 

Read more »